Comcare is holding a series of Australia-wide forums focusing on the transition to the new international system of chemical labelling and classification. [ + ]

A new drug could be used to repair the blood vessel defects that prevent current anticancer treatments from entering tumours. [ + ]

The Office of the Chief Scientist has released a detailed analysis of Australia's science, technology, engineering and mathematics (STEM) trained workforce. [ + ]

The Australian Institute of Medical Scientists and the UK Institute of Biomedical Science have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations. [ + ]

Semifinalists in the science communication competition FameLab will take to the stage on 7 April at the Powerhouse Museum, Sydney. [ + ]

The Australian Research Council has announced the members of the two Engagement and Impact working groups that will assist in the development of a research engagement and impact assessment for Australia. [ + ]

WellSpring Pharma Services has agreed to manufacture two to three pharmaceutical products that require manufacturing processes or scale not currently available at IDT's Boronia facilities. [ + ]

Opthea has completed patient enrolment in its ongoing phase 1 dose escalation clinical trial of OPT-302 as a novel therapy for wet age-related macular degeneration (wet AMD). [ + ]

Scientists from The University of Western Australia have used fluorescent green dye to observe different sperm competing to fertilise eggs. [ + ]

MecRx has secured a $4 million investment from the Medical Research Commercialisation Fund to advance its breakthrough technology for accelerating drug discovery. [ + ]

Researchers have proposed a way to improve the beam quality of laser wakefield accelerators, also known as benchtop accelerators. [ + ]

The Prostate Cancer Foundation of Australia has opened its annual funding round with the aim of supporting groundbreaking prostate cancer research. [ + ]

Two proteins from the tuberculosis bacterium are showing promising results in investigations in mice for a new vaccine. [ + ]

Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for its Phase IIb clinical trial of NTCELL for Parkinson's disease. [ + ]

Forensic researchers have established science-based standards for identifying human remains based on X-rays of an individual's spine, upper leg or the side of the skull. [ + ]